I get chills whenever we make another API available via LPT (a chewable liposomal tablet).
GHK-Cu now available, along with Testosterone and Tirzepatide 👀
Stoked on this tech.
@AbudBakri Most states accept what the FDA says when it comes to API-related matters. I believe states that have additional concern will be the minority
TikTok has fully banned all content about peptides
Searching "bpc-157" "melanotan" shows "No results found"
Searching "reta" gives you eating disorder resources
Might (or might not) be the same molecule, but the REAL variables that carry risk are the environments where they’re made and how they’re made, and the lack of medical oversight.
We live in a small corner of the internet here on X. A grandma absolutely should be getting medical supervision while using peptides.
These variables matter, even if the API/molecules come from the same place
There are such thing as compounders that operate below board. That’s true, HOWEVER, because it’s in a regulated industry, one surprise inspection when they’re doing things wrong could shut them down.
In any business, not all players are created equal, but the fact that it’s in a regulated industry makes it much more net positive.
I’m just encouraging providers to be selective. Do their homework. Ask for receipts. Make sure the pharmacy you use is one of the good ones.
Want to utilize @strivepharmacy as your source of compounded peptides? I suggest getting signed up as a authorized prescriber NOW before the wave hits https://t.co/ajB9vOQn9G
We’re ready.
HOLY 💩, HERE IT IS. The six peptides PCAC recommended are on the interim enforcement discretion policy, to be published Oct 30! https://t.co/qdP95rXESz
Peptides are BACK like they never shoulda left!
@BadTechBandit@strivepharmacy Yes. We are just the pharmacy… but the BEST pharmacy 😎
We’re agnostic, so we serve any compliant clinic rather than just bring fulfillment for a vertically integrated telehealth
HOLY 💩, HERE IT IS. The six peptides PCAC recommended are on the interim enforcement discretion policy, to be published Oct 30! https://t.co/qdP95rXESz
Peptides are BACK like they never shoulda left!
This couldn’t be more true. We think the general population is so educated on how to navigate RUO safely, but here on X is such a small corner of the Internet. It’s everybody else that really has no idea what they are doing, where the real risk lies. I’m so, so excited for more grandmas to get BPC
Don’t be humble, @LeeRosebush. You’ve done more than anyone else at this point in making it a reality. Thanks for all the time away from family, blood, sweat, tears, etc to help facilitate making this possible.
Let’s hear it for Lee!
Looking for a provider that utilizes @strivepharmacy as their pharmacy for peptides? We built a tool that helps you find one in your area. Prescription required! https://t.co/N72YKMj4RE
Want to utilize @strivepharmacy as your source of compounded peptides? I suggest getting signed up as a authorized prescriber NOW before the wave hits https://t.co/ajB9vOQn9G
We’re ready.
Slowly, then all at once.
One step closer to regulated/prescribed access to more peptides.
This step came sooner than expected tbh since there are still meetings on the calendar for it 🤔
Either way, thrilled with this update.
Practicioners, develop your partnerships with pharmacies you trust, NOW.
Make sure they do things right—for all our sakes.
$HIMS
🚨 BREAKING: FDA PEPTIDE POLICY PASSES WHITE HOUSE REVIEW
NOW MARKED "CONSISTENT WITH CHANGE" ON REGINFO DATABASE
- Review officially concluded Oct. 27
- FDA can now move toward issuing its interim peptide compounding policy
- Likely to expand access to certain peptides (eg, BPC-157, TB-500) under regulatory safeguards
- Awaiting official FDA publication, could happen any time